SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 27.47 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 9.04 |
| Book Value / Share | 0.78 |
| Price / Book | n/a |
| NCAV ($M) | 4.98 |
| NCAV / Share | 0.43 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.26 |
| Return on Assets (ROA) | -0.23 |
| Return on Equity (ROE) | -0.25 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.89 |
| Current Ratio | 9.89 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6.00 |
| Assets | 10.07 |
| Liabilities | 1.02 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 1.13 |
| Operating Income | -2.52 |
| Net Income | -2.52 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -2.71 |
| Cash from Investing | 1.13 |
| Cash from Financing | -0.06 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | mDR Ltd | 11.33 | -2.17 | |
| 13D/A | Choo Chee Kong | 23.17 | -40.44 | |
| 13G | 28 Consultants Ltd | 7.62 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 584 | 20,052 | 2.91 | |
| 2,379 | 7,986 | 29.79 | |
| 2,801 | 29,857 | 9.38 | |
| 2,841 | 33,313 | 8.53 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FLGC – Flora Growth Corp. | FTLF – FitLife Brands, Inc. |
| GALT – Galectin Therapeutics Inc. | GELS – Gelteq Limited |
| GLMD – Galmed Pharmaceuticals Ltd. |
Financial data and stock pages provided by
Fintel.io